share_log

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $9

Benzinga ·  Jul 3, 2023 06:11

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and lowers the price target from $10 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment